The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk factors and a model to predict toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: Results from the International Metastatic RCC Database Consortium.
 
Marina Dusevic Kaymakcalan
No Relationships to Disclose
 
Wanling Xie
No Relationships to Disclose
 
Laurence Albiges
Consulting or Advisory Role - Amgen; Novartis; Pfizer; Sanofi
Speakers' Bureau - Novartis; Pfizer
Research Funding - novartis; pfizer
Travel, Accommodations, Expenses - Amgen; Novartis
 
Scott A. North
Honoraria - Astellas Pharma; Janssen-Ortho; Novartis; Pfizer
 
Christian K. Kollmannsberger
No Relationships to Disclose
 
Martin Smoragiewicz
No Relationships to Disclose
 
Nils Kroeger
Travel, Accommodations, Expenses - Astellas Pharma; GlaxoSmithKline; Pfizer
 
Connor Wells
No Relationships to Disclose
 
Sun Young Rha
No Relationships to Disclose
 
Jae-Lyun Lee
Honoraria - Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer
 
Andre Poisl Fay
No Relationships to Disclose
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Bayer; Novartis; Pfizer
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer